Bills of Congress by U.S. Congress

S.735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 (119th Congress)

Summary

S.735, the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025, aims to reauthorize and amend the Public Health Service Act concerning sickle cell disease. The bill focuses on enhancing treatment and prevention efforts related to sickle cell disease and its complications. It also increases funding for related programs and encourages further research into heritable blood disorders.

Expected Effects

The bill will likely lead to increased funding for sickle cell disease treatment and prevention programs. It will also broaden the scope of these programs to include complications arising from the disease. Furthermore, the bill may stimulate further research into the causes and potential cures for heritable blood disorders.

Potential Benefits

  • Improved treatment and prevention of sickle cell disease complications.
  • Increased funding for relevant programs.
  • Potential for advancements in understanding and treating heritable blood disorders.
  • Enhanced public health outcomes for individuals affected by sickle cell disease.
  • Supports research and development in the medical field.

Potential Disadvantages

  • Increased government spending, potentially impacting the federal budget.
  • Limited scope, focusing primarily on sickle cell disease and related disorders, potentially neglecting other public health concerns.
  • Potential for bureaucratic inefficiencies in grant distribution and program implementation.
  • The bill's success depends on effective program management and research outcomes.
  • May not address the underlying socioeconomic factors contributing to health disparities.

Constitutional Alignment

The bill aligns with the Constitution's mandate to "promote the general Welfare" (Preamble). Congress has the power to legislate on matters related to public health under the Commerce Clause (Article I, Section 8) and the Necessary and Proper Clause (Article I, Section 8). The bill does not appear to infringe on any specific constitutional rights or limitations.

Impact Assessment: Things You Care About

This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).